CLINICAL_TRIALS trial_result · 2022-10-06

Clinical Trial Update: Exeantide in Type 2 Diabetes on Insulin [Phase 2]

A Phase 2 trial evaluating Exeantide in patients with Type 2 Diabetes who are on insulin has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University at Buffalo | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2022-10-06